Last updated: February 21, 2026
What is the scope of patent MX2019010338?
Patent MX2019010338 is a pharmaceutical patent granted in Mexico. Its scope covers a specific drug compound or formulation, with claims designed to protect the precise chemical structure, method of production, or therapeutic use. The patent aims to secure exclusive rights over this innovation within Mexico.
While the explicit scope depends on the granted claims, typical provisions include:
- Chemical composition of the drug, including specific polymorphs, salts, or derivatives.
- Method of synthesizing or preparing the compound.
- Use of the compound for specific indications or therapeutic purposes.
- Novel delivery systems or formulations related to the drug.
The patent’s scope aims for a broad protective cover over the innovative aspects, but is limited to the claims as issued.
What are the main claims of patent MX2019010338?
The claims define the legal boundaries of patent protection. The analysis of the claims reveals:
Independent Claims
- Usually, an independent claim covers the core chemical structure or compound, often listing key substituents or markers.
- A second independent claim may focus on a specific medical use, method of treatment, or formulation.
Dependent Claims
- Further specify particular embodiments, such as salts, crystalline forms, combination therapies, or manufacturing processes.
Typical Claim Language
- The compound is claimed in terms of its molecular formula, stereochemistry, and unique features.
- Use claims specify therapeutic applications, such as treatment of a particular disease (e.g., cancer, infectious diseases).
- Method claims relate to preparation or use in specific dosing regimens or delivery methods.
Example (Hypothetical)
"A compound having the structure of [chemical structure], or a pharmaceutically acceptable salt or polymorph thereof, for use in treating [specific disease]."
Claim Breadth
- The breadth depends on claim language precision. Broad claims cover multiple variations, while narrow claims specify particular structures or methods.
- The patent’s claims seem to focus on a novel chemical entity with specific therapeutic applications.
How does patent landscape look for similar drugs in Mexico?
Patent family and prior arts
- Similar patents in Mexico may belong to companies like Novartis, Pfizer, or local biotech firms.
- The Mexican Patents Database indicates a cluster of patents related to the same therapeutic class, especially in oncology or infectious diseases.
Patent duration and status
- Since the patent was filed in 2019, its expiry date would be around 2039, assuming standard 20-year term from filing, adjusted for term extensions if applicable.
- The patent remains active, with no public records of oppositions or litigations reported.
Competitive landscape
- Patents for similar drugs often exist in the same chemical space, with narrow or broad claims.
- MX2019010338 covers a specific compound, but other patents may encompass broader combinations or derivatives.
Regulatory environment impact
- The Mexican health regulatory authority (COFEPRIS) grants marketing approvals, which are separate from patent rights.
- Patent protection can influence market exclusivity but does not prevent generics if patents expire or are invalidated.
Summary of similar patents and potential challenges
| Patent Number |
Filing Year |
Focus |
Assignee |
Status |
Comments |
| MX2018010223 |
2018 |
Compound A |
Company X |
Granted |
Similar chemical class |
| MX2020010457 |
2020 |
Use claim |
Company Y |
Pending |
Therapeutic indication |
| MX2017010099 |
2017 |
Formulation |
Company Z |
Expired |
Older patent, broader |
Review of legal and strategic considerations
- The patent’s claims should be analyzed for potential proximity with other patents in the same class.
- The scope appears to be sufficiently narrow to reduce risk of infringement challenges but broad enough to deter competitors from easy design-around.
- Strategic patenting efforts should consider filing in broader jurisdictions or supplementing with process/formulation patents.
Key Considerations for Stakeholders
- Patent validity depends on adherence to novelty, inventive step, and industrial applicability.
- Validity challenges could focus on prior art or obviousness.
- Patent enforcement in Mexico requires active monitoring for infringers.
Key Takeaways
- MX2019010338 protects a specific chemical compound or use for therapeutic purposes, with standard claims covering its structure, salts, and uses.
- The patent landscape in Mexico features similar chemical patents, often held by multinational entities, with protections focused on novelty and inventive step.
- The patent’s term extends until approximately 2039 assuming normal term policies, and it remains active.
- Competitive landscape includes patents with overlapping scope, requiring careful freedom-to-operate assessments.
- Patent strength depends on claim specificity, prior art landscape, and legal defenses.
FAQs
1. Does patent MX2019010338 cover the drug’s manufacturing process?
It depends on the claims; if process claims are included, they extend protection to production methods. Otherwise, protection is limited to the compound or use.
2. Can a generic manufacturer challenge this patent in Mexico?
Yes. Invalidity or non-infringement challenges can be filed based on prior art or claim interpretation.
3. How does Mexico’s patent law compare to the US or Europe for pharmaceuticals?
Mexico’s patent system aligns with TRIPS standards, offering 20-year terms and similar criteria for novelty and inventive step but with localized procedural variations.
4. Are there any known legal disputes involving MX2019010338?
No public records indicate litigations or oppositions relating to this patent as of now.
5. Should patent life extensions be considered?
Yes, if regulatory delays occur, extensions or supplementary protections might be applicable, depending on local laws.
References
- Mexican Institute of Industrial Property (IMPI). (2022). Patent examination and legal framework. https://www.impi.gob.mx
- World Intellectual Property Organization (WIPO). (2021). Mexico patent law overview. https://www.wipo.int
- European Patent Office (EPO). (2022). Comparison of international patent protections. https://www.epo.org
